IRIDEX Corp (NAS:IRIX)

Q2 2025 IRIDEX Corp Earnings Call Transcript

Aug 12, 2025 / 09:00 PM GMT

Release Date Price: $1.3 (+3.17%)

Transcript 10-Q8-K

Key Points

Positve

IRIDEX Corp (IRIX) achieved a 7% year-over-year revenue growth and a 14% sequential growth over the first quarter of 2025.
The company successfully reduced operating expenses by 28% compared to the prior year period, contributing to improved financial health.
IRIDEX Corp (IRIX) reported positive adjusted EBITDA for the third consecutive quarter, indicating a successful business transformation.
The Pascal system sales exceeded expectations in the US, showing strong customer demand and consistent momentum.
The company identified additional opportunities to reduce operating expenses and improve gross margins, including negotiating with contract manufacturers and planning to relocate to a less expensive facility.

Negative

Gross margin decreased to 34.5% from 40.7% in the second quarter of 2024, primarily due to increased manufacturing costs and product mix.
The company faced challenges in Asia due to uncertainty around the tariff dispute with China, affecting supply chains and potentially future quarters.
Pascal sales in Latin America and Canada fell short of expectations due to pricing pressures.
G6 probe sales were materially lighter than expected due to supply constraints impacting order shipments at the end of the quarter.
The glaucoma business in Asia remained stagnant, with no signs of growth in the G6 probe business.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IRIX.OQ - IRIDEX Corp
Q2 2025 IRIDEX Corp Earnings Call
Aug 12, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the 2nd quarter of 2025 Iridex earnings conference call. All lines have been placed on mute to prevent any background noise. I'd now like to turn the conference over to Trip Taylor, Investor Relations. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and thank you all for participating in today's call. Joining me from the company are Patrick Mercer, Iridex's Chief Executive Officer, and Romeo Dezon, the company's Chief Financial Officer.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.